KINTOR PHARMA-B(09939) completed the issuance of 30.4875 million new shares.
Kangtuo Pharmaceutical-B (09939) announced that all conditions of the agreement have been met, and the agreement has been finalized according to the terms of the agreement...
KINTOR PHARMA-B (09939) announced that all conditions of the agreement have been met, and the agreement was completed on November 21, 2025, in accordance with the terms and conditions of the agreement. The company issued and distributed 30,487,500 new shares to subscribers at a price of HK$1.64 per share on November 21, 2025, in accordance with the terms and conditions of the agreement. The subscribed shares represent approximately 6.11% of the company's enlarged issued share capital after the subscription.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


